Codexis to Participate in Enzymatic Synthesis Presentations at RNA Leaders Annual MeetingGlobeNewsWire • 08/20/24
Codexis Finalizes Purchase Agreement with Crosswalk Therapeutics for Gene Therapy AssetsGlobeNewsWire • 07/01/24
Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual MeetingGlobeNewsWire • 05/14/24
Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with RocheGlobeNewsWire • 02/26/24
Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory BoardGlobeNewsWire • 02/20/24
Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28GlobeNewsWire • 02/14/24
Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key MilestonesGlobeNewsWire • 02/13/24
seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General MeetingGlobeNewsWire • 02/01/24
Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA PolymeraseGlobeNewsWire • 12/13/23